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To determine whether self-rated health of patients with motor functional neurologic disorder
(FND) can be improved by unguided Internet-based self-help and education.
Methods
In this nonblinded randomized controlled trial, patients were allocated 1:1 unbiased to an
unguided education and self-help website in addition to usual care or usual care only. Patients
over 17 years of age with a functional motor symptom that caused distress or disability were
included. The primary outcome was self-rated health on the Clinical Global Improvement scale
at 3 and 6 months. Secondary outcomes were severity of motor symptoms, other physical and
psychiatric symptoms, physical functioning, quality of life, work and social adjustment, illness
beliefs, and satisfaction with care.
Results
A total of 186 patients were randomized, with a follow-up rate of 87% at 6 months. There was
no difference in improvement of self-rated health at 3 months (44% vs 40%, p = 0.899) or 6
months (42% vs 43%, p = 0.435). Secondary outcomes did not differ between groups, with a
threshold of p < 0.01. Satisfaction was high, with 86% of patients recommending the website to
other patients.
Conclusion
We found no significant effect of the intervention added to usual care on self-rated health or
secondary outcome measures, despite high patient satisfaction with the intervention. These
results suggest that online education and nonguided self-help could be valuable additions to




This study provides Class III evidence that for patients with motor FND, online education and
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Education and self-help intervention are thought by many
clinicians to be an important component of treatment for
motor functional neurologic disorder (FND) but evidence of
effectiveness is lacking.1,2 Prognostic studies in FND and
other functional disorders have shown a correlation between
confidence in the diagnosis and good outcome3–8 and satis-
faction with care.9,10 By contrast, patient groups have
expressed concerns that information alone should not be a
substitute for (multidisciplinary) treatment.
In patients with FND, a guided self-help study showed modest
improvements in the intervention group and no harmful ef-
fects.6 No studies of unguided self-help have been performed in
FND.11
For this study, we developed a nonguided web-based pro-
gram for motor FND aiming to improve patients’ un-
derstanding of the disorder and encourage patients to take
an active role in their treatment. Our model of motor FND
was of involuntary motor symptoms arising from disordered
nervous system functioning and a disorder at the interface
between neurology and psychiatry. This includes changes in
predictive processing,12 occurring in the context of bi-
ological, psychological, or social factors that vary consider-
ably between patients.13
We aimed to find out whether provision of this website added
to usual care improved self-rated health status using clinical
global improvement in patients withmotor FND compared to
usual care only. We also aimed to measure the impact of
additional information on the severity of motor symptoms,
other physical and psychiatric symptoms, physical function-
ing, quality of life, work and social adjustment, illness beliefs,
and satisfaction with treatment.
Methods
Study design and procedures
This was a 2-group parallel superiority nonblinded random-
ized controlled trial (RCT) with patient-rated outcomes at 3
and 6 months. Between October 2015 and July 2017, neu-
rologists from 31 neurology centers across the Netherlands
referred eligible patients to the study.
Patients received information about the study procedures in
the mail or via e-mail and gave written informed consent
before they were enrolled in the study. The information they
received stated the study consisted of a 2-group comparison
in which one group would gain access to a website with
information and self-help. They could contact the investi-
gators for consultation about the study before enrollment
but not afterwards.
After giving consent and completing the online baseline
questionnaires, patients were randomized unbiased into
2 arms. The intervention group received access to the
password-protected unguided education and self-help
website as an addition to usual care. They were instructed
to read the website at their own pace and preference. The
control group received usual care only. “Usual care” in both
groups was not standardized and included any treatment
patients received during the trial. Patients were not allowed
to discuss medical problems with the investigator (JMG)
after randomization. This was not violated. All outcome
measures were self-report, using online questionnaires at
3 and 6 months.
Standard protocol approvals, registrations,
and patient consents
The SHIFT study (Self-Help and Education on the Internet
for Functional Motor Disorders) was performed in accor-
dance with the ethical and legal guidelines of the University
Medical Center Groningen (METc 2015/141, M14.150920).
All participants gave written consent. The trial was registered
at clinicaltrials.gov (NCT02589886).
Primary research question
Does provision of a self-help and education website added to
usual care improve the self-rated health status in patients with
motor FND compared to usual care only at 3 and 6 months
follow-up?
Our study provides Class III evidence to answer this question.
Participants
Inclusion criteria were (1) 18 years of age or older; (2)
functional motor symptom (limb weakness or movement
disorder) diagnosed by a neurologist; (3) symptoms
causing distress or impairment in social, occupational, or
other important areas of functioning or that warrant
medical evaluation (definition according to DSM-5); (4)
able to read the Dutch language; and (5) access to a
computer with an Internet connection on a regular basis.
We excluded (1) patients who were unable to provide
informed consent; (2) patients with other (functional)
complaints, in whom the motor symptom was an acci-
dental finding in neurologic investigation (i.e., where
Glossary
CGI = Clinical Global Improvement; DSM-5 = Diagnostic and Statistical Manual of Mental Disorders, 5th edition; FND =
functional neurologic disorder; IQR = interquartile range; OR = odds ratio; RAND36 = Dutch equivalent of Short Form–36
health-related quality of life; RCT = randomized controlled trial;WHO-QoL = a single question from the 1998 WHOQuality
of Life scale; WI = Whitely Index; WSAS = Work and Social Adjustment Scale.
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motor symptoms were not an impairing symptom), which
was assessed by the referring neurologist; and (3) patients
who were known visitors of the (previously available, but
during the study offline) translated (Dutch) version of a
website by J.S. (see below). This was assessed in the
baseline questionnaire. Patients with comorbid (neuro-
logic) disease were not excluded from the study.
Intervention
The tested intervention was a newly developed educa-
tional website in Dutch, which included self-help elements.
A pdf version of the website can be found as supplementary
material. The content was in line with the explanatory
model described by Stone et al.14 It combined elements of
a website developed by J.S., neurosymptoms.org, a self-
help workbook developed for functional neurologic
symptoms,6 and expert opinion of J.S., M.A.J.T., J.G.M.R.,
A.C., and G.N.
The website consisted of 4 blocks focusing on different do-
mains, and included several different sources of information
(figure 1). The website also included exercises adapted from
physiotherapy recommendations from Nielsen et al.15 It was
piloted and altered based on the feedback of 12 patients and
their family members for intelligibility, clearness, relevance,
and applicability. Readability scored level B1, with a moderate
Douma readability score of 64 out of 100 (based on the En-
glish Flesh-Kincaid test), corresponding with a reading age of
13/14 (adjusted for “functional” and “disorder”).
Outcome measures
The main outcome was self-rated health, measured on the
Clinical Global Improvement (CGI) scale, a 7-point Likert
scale (high scores correspond to poor health) at 3 and 6
months.
Secondary outcome measures were severity of all individual
motor symptoms (self-rated change in presenting symptom
scale [range 0–7]), fatigue (Checklist Individual Strength,
fatigue severity subscale [range 7–56]), pain (RAND36,
the Dutch equivalent of the Short Form–36, subscale
[range 0–100]), depressive symptoms (Patient Health
Questionnaire–9 [range 0–27]), anxiety (Generalized
Anxiety Disorder questionnaire [scores 0–14]), health
Figure 1 Overview of the nonguided self-help website
The left panel shows examples of pages and descriptions of the content of the 4 blocks on general functional neurologic disorder (FND) (1); specific motor
symptoms that patients could choose (2); and rehabilitation advice, exercises, and information on treatment possibilities (3) and on the influence of FND on
daily life (4). The right panel shows the different media that were used to provide information, which were mostly newly developed for this study.
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Age, y, mean (SD) 48 (15) 49 (15)
Sex, % female 73 70
Not in work 78 70
For nonmedical reasons 20 16
On health-related benefits <2 years 21 16
On health-related benefits >2 years 37 38
Referring center (% academic hospital) 55 55
Symptoms
Duration of motor symptoms, mo, mean (SD) 70 (108) 66 (105)
Severity of all presenting motor symptoms (CPS) (% moderately severe/severe/very severe) 81 82





Gait disorder 15 18
Mixed/unclear 17 12
Pain (RAND36), median (IQR) 45 (55) 57 (47)
Fatigue (CIS severity), median (IQR) 44 (16) 46 (17)
Depression (PHQ-9), median (IQR) 9 (9) 7 (7)
Anxiety (GAD-7), median (IQR) 6 (10) 5 (9)
Health anxiety (WI), median (IQR) 3 (2) 3 (2)
Self-rated health, quality of life, and functioning
Self-rated health (CGI), % moderately bad and bad and very bad 43 39
Quality of life (WHO-QoL), % good and very good 32 29
Physical functioning (RAND36), median (IQR) 40 (45) 40 (50)
Work and social adjustment (WSAS), median (IQR) 26 (18) 26 (15)
Illness beliefs and satisfaction with care, % agree and strongly agree
I am confident that the diagnosis functional disorder is correct. 63 61
I am afraid that something (e.g., a possible serious diagnosis) has been missed when making
the diagnosis.
15 17
My symptoms are caused by stress/worry or psychiatric problems in the past. 19 25
FND are disorders of the nervous system. 56 51
My disorder is a mystery to me (IPQ). 56 48
What I do determines the outcome of my disorder (IPQ). 54 63
My disorder is permanent rather than temporary (IPQ). 51 48
I think physiotherapy will improve my symptoms. 37 33
Continued
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anxiety (Whiteley Index [range 0–7]), health-related
quality of life and functioning (RAND36) and quality of
life (using a single question from the 1998 WHOQuality of
Life scale: “How would you rate your quality of life?”) (5-
point Likert scale, 5 representing good quality of life), and
work and social adjustment (Work and Social Adjustment
Scale [WSAS] [range 0–40]). Illness perception, satisfac-
tion with care, and confidence in physiotherapy and psy-
chotherapy were assessed by the level of agreement on a
5-point scale on several statements, partly derived from the
Illness Perception Questionnaire (tables 1 and 2) and the
patient satisfaction questionnaire. Hospitalizations, visits
to other websites on FNS, and other treatments were
recorded. Open fields were available for additional com-
ments, including comments on improvement if that
occurred.
A combination of patients’ self-report and the number of
times they logged on to the website was used to record use of
the website. Evaluation of the intervention website was carried
out by agreement on a series of statements on a 5-point scale
(not at all–strongly agree) (table 3). If patients did not fill out
the online questionnaires, they were contacted by phone at 6
months to assess the main outcome, change in presenting
symptoms, quality of life, and agreement with the statements
“I would recommend this website to other patients” and “The
website helped me a lot.”
Baseline data from this study were used in another publication
on fatigue severity.16
Sample size
Sample size calculation, using Fisher exact proportions for
independent groups test in G-power version 3.1.7 software,
was based on the expected percentage of patients showing any
improvement on the CGI self-rated health scale (all scores
below 4 “no change”). Based on a previous RCT on self-help,6
our prognosis review,3 and a pilot study of 10 patients in
which 40% of patients improved, we estimated that 20% of
patients would improve in both groups and an additional 20%
in the intervention group. With an alpha of 0.05 and a power
of 0.80, a 2-tailed calculation resulted in a sample size of 90
patients per group. To anticipate drop out, we aimed for 100
patients per group. No interim analyses were performed.
Randomization and blinding
Block randomization with stratification, with a ratio of 1:1 into
the intervention and control group, was performed by an
online randomization tool, ALEA, programmed by the Clin-
ical Research Desk of the University Medical Center Gro-
ningen. Stratification factors were having limb weakness as a
mainmotor symptom and duration of symptoms >1 year. The
investigators were unaware of the trial group assignments
during randomization.
Patients were not blinded to the intervention allocation, be-
cause of the obvious difference between the 2 groups (with
and without access to the website). Investigators were not
blinded: outcome measures were collected remotely via an
online form (with equal procedures in both groups), without
interference of the investigator. All research data were ano-
nymized before analysis.
Statistical analysis
An intention-to-treat analysis was performed at 3 and 6
months after randomization. A between × within design was
used, by subtracting outcome and baseline values and com-
paring the differences between groups. Mann-WhitneyU tests
(using the whole scale) and χ2 tests were used for non-
parametric and t tests for normally distributed variables.





I think psychotherapy will improve my symptoms. 19 17
I have confidence in my neurologist. 65 58
My neurologist and I agree on the nature of my symptoms. 61 52
I would recommend the care I received to other patients. 27 31
Communication with doctors (PSQ) 3 (1) 3 (1)
Interpersonal relation doctors (PSQ) 4 (1) 4 (1)
Technical quality of doctors (PSQ) 3 (1) 3 (1)
Abbreviations: CGI = Clinical Global Improvement; CIS = Checklist Individual Strength; CPS = change in presenting symptoms scale; FND = functional
neurologic disorder; GAD-7 = Generalized Anxiety Disorder Questionnaire, health anxiety; IPQ = Illness Perception Questionnaire; IQR = interquartile range;
PHQ-9 = Patient Health questionnaire; PSQ = patient satisfaction questionnaire; RAND36 = Dutch equivalent of Short Form–36 health-related quality of life;
WHO-QoL = a single question from the 1998 WHO Quality of Life scale; WI = Whitely Index; WSAS = Work and Social Adjustment Scale (see tables 1 and 2).
Higher scores represent poor outcome in CGI, CPS, CIS, PHQ, GAD,WI, andWSAS; higher scores represent good outcome in RAND36. All statements on illness
and satisfaction agreement were measured on a 5-point Likert scale (1 = totally disagree, 2 = disagree, 3 = neither agree nor disagree, 4 = agree, 5 = totally
agree), percentages are displayed for readability, and statistics were performed on the whole scale. Values are presented as percentages unless indicated
otherwise.
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Table 2 Outcome measures at 3 and 6 months in the intervention and control group (intention-to-treat)




Group comparisonN % N % N % N %
Self-rated health (CGI), % improved 70 44 65 40 U = 2,247; p = 0.899 84 42 79 43 p = 0.435
Symptoms, median (IQR)/% improved
Severity all motor symptoms, % improved 70 53 65 38 U = 2,247; p = 0.899 84 42 79 44 U = 3,087; p = 0.435
% Of totally remitted motor symptoms 70 5 65 0 — 84 6 79 4 —
Pain (RAND36) 69 55 (68) 65 57 (44) U = 2,239; p = 0.989 79 55 (68) 69 57 (40) U = 2,563; p = 0.533
Fatigue (CIS severity) — — — — — 71 42 (20) 66 44 (23) U = 2,180; p = 0.674
Depression (PHQ-9) 69 6 (7) 65 7 (6) U = 1756; p = 0.040 79 6 (8) 69 6 (8) U = 2,170; p = 0.056
Anxiety (GAD-7) 70 5 (9) 65 4 (8) U = 2,250; p = 0.912 79 5 (9) 69 5 (8) U = 2,704; p = 0.933
Health anxiety (WI) — — — — — 74 2 (4) 68 2 (2) U = 2,419; p = 0.689
Quality of life and functioning, median (IQR)
Quality of life (WHO-QoL), % good, very good 70 41% 65 29 U = 2,232; p = 0.838 84 40 79 42 U = 3,290; p = 0.863
Physical functioning (RAND36) 70 50 (61) 65 40 (53) U = 2,274; p = 0.996 79 40 (65) 69 45 (58) U = 2,407; p = 0.217
Work and social adjustment (WSAS) 70 21 (19) 65 25 (14) U = 2,170; p = 0.643 81 25 (18) 69 24 (18) U = 2,757; p = 0.887
Illness beliefs and satisfaction with care, % agree/strongly agree
I am confident that the diagnosis functional disorder is correct. 73 62 66 47 U = 1863; p = 0.014 76 58 70 56 U = 2,346; p = 0.193
I am afraid that something (e.g., possible serious diagnosis) has been missed. 72 18 66 17 U = 2,104; p = 0.220 79 20 69 19 U = 2,347; p = 0.718
Symptoms are caused by stress/worry or psychiatric problems in the past. 73 19 66 23 U = 2,277; p = 0.548 76 21 69 20 U = 2,502; p = 0.610
Functional movement disorders are disorders of the nervous system. 73 60 66 52 U = 2,329; p = 0.719 76 39 69 48 U = 2,561; p = 0.801
My disorder is a mystery to me (IPQ). 73 41 66 47 U = 2,112; p = 0.246 76 34 69 46 U = 2,286; p = 0.211
What I do determines the outcome of my disorder (IPQ). 73 59 66 65 U = 2047; p = 0.116 76 45 69 57 U = 2,319; p = 0.217
My disorder is permanent rather than temporary (IPQ). 73 48 66 55 U = 2,197; p = 0.344 77 58 69 65 U = 2,448; p = 0.389
Exercise worsens my symptoms. 73 51 66 56 U = 1,989; p = 0.072 76 49 69 64 U = 2,161; p = 0.035
I think physiotherapy will improve my symptoms. 73 41 66 36 U = 2,020; p = 0.089 76 41 69 26 U = 2,148; p = 0.052














































For the main outcome, missing data were imputed, by means
of multiple imputation methods using linear regression in
SPSS (version 23). We imputed missing data based on all
baseline and follow-up variables, generating 5 new datasets.
These were used for a sensitivity analysis (to explore the effect
of dropout). In the data displayed in the tables and outcomes,
data without imputation are provided.
An additional per protocol analysis was planned, excluding
patients who never logged on to the website from the in-
tervention group, to investigate whether the website itself has
a beneficial effect, but would need promotion.
Post hoc we analyzed the effect of change between baseline and
follow-up on agreement with the statements “I am confident that
the diagnosis functional disorder is correct,” “My disorder is a
mystery to me,” and “What I do determines the outcome of my
disorder” on the main outcome. Furthermore, we investigated a
limited number of possible prognostic factors (baseline factors
that influence outcome): duration of symptoms, type of referring
center (academic vs nonacademic), age, sex, and the same illness
perception statements as listed above. For these correlations, we
used univariable ordinal regression models, first in the entire
cohort, and second with randomization group added to the
model, to investigate associations between groups.
Due to multiple comparisons, secondary outcome measures
were interpreted conservatively with p values of greater than
0.01 treated with caution.
Data availability
Data are available on request from the authors.
Results
Participants
A total of 355 patients were screened for eligibility, of whom
186 participated in the study. Randomization resulted in 93
patients for each group at baseline. The flowchart (figure 2)
summarizes reasons for exclusion and loss to follow-up.
Reasons for not visiting the website varied. At 3 months, some
patients reported forgetting about it (n = 4), believing (n = 2)
or being concerned (n = 2) about undesirable content, allevi-
ated symptoms (n = 1), skepticism regarding diagnosis (n = 1),
and various additional reasons. Between 3 and 6 months, most
patients (n = 44) ceased further website visits, primarily due to
improved symptoms (n = 7), having fully read the website (n =
8), being focused on a different treatment (n = 5), and severe
symptoms or impaired concentration (n = 5). Two patients
disagreed with the content, citing dislike of the term “disorder”
and uninformative content; another 2 “did not feel like” visiting
the site.
Baseline
The majority of patients were female (72%) and many were
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Table 3 Per protocol analysis




Group comparisonN % N % N % N %
Self-rated health (CGI), % improved 58 45 65 40 U = 1,879; p = 0.975 78 42 79 43 U = 2,851; p = 0.412
Symptoms, median (IQR)/% improved
Severity all motor symptoms (CPS) 63 51 66 38 U = 1,982; p = 0.641 79 51 79 44 U = 3,002; p = 0.581
Pain (RAND36) 57 45 (58) 65 57 (43) U = 1,816; p = 0.851 73 45 (68) 69 57 (40) U = 2,370; p = 0.543
Fatigue (CIS severity) NA NA 66 43 (21) 65 44 (13) U = 2,023; p = 0.574
Depression (PHQ-9) 57 7 (8) 65 7 (5) U = 1,517; p = 0.084 71 8 (9) 69 6 (8) U = 2,041; p = 0.088
Anxiety (GAD-7) 58 6 (10) 65 4 (8) U = 1,863; p = 0.909 73 5 (9) 69 5 (8) U = 2,485; p = 0.887
Health anxiety (WI) NA NA 70 2 (3) 68 2 (2) U = 2,293; p = 0.705
Quality of life and functioning, median (IQR)/% good
Quality of life (WHO-QoL), % good/very good 58 67 65 29 U = 1,833; p = 0.776 78 37 79 41 U = 2,909; p = 0.531
Physical functioning (RAND36) 58 48 (67) 65 40 (52) U = 1,870; p = 0.937 73 40 (65) 69 45 (58) U = 2,477; p = 0.865
Work and social adjustment (WSAS) 58 22 (18) 65 25 (13) U = 1,779; p = 0.588 75 26 (19) 69 24 (18) U = 2,380; p = 0.405
Illness beliefs and satisfaction with care, median (IQR)
I am confident that the functional disorder diagnosis is correct. 59 61 66 47 U = 1,487; p = 0.014 70 58 70 56 U = 2,114; p = 0.138
I am afraid that something (e.g., possible serious diagnosis) has been missed. 58 14 66 17 U = 1,667; p = 0.189 70 23 69 19 U = 2,214; p = 0.373
Symptoms are caused by stress/worry or psychiatric problems in the past. 59 19 66 23 U = 1,883; p =0.731 70 20 69 20 U = 2,234; p = 0.409
Functional movement disorders are disorders of the nervous system. 59 59 66 52 U = 1,860; p = 0.649 70 59 69 48 U = 2,396; p = 0.933
My disorder is a mystery to me (IPQ). 58 40 66 47 U = 1,603; p = 0.108 69 31 69 46 U = 2,042; p = 0.134
What I do determines the outcome of my disorder (IPQ). 59 63 66 65 U = 1,759; p = 0.335 70 46 69 57 U = 2,152; p = 0.252
My disorder is permanent rather than temporary (IPQ). 59 46 66 55 U = 1,644; p = 0.111 71 59 69 65 U = 2,225; p = 0.323
Exercise worsens my symptoms. 59 51 66 59 U = 1,579; p = 0.065 70 55 71 62 U = 2,003; p = 0.044
I think physiotherapy will improve my symptoms. 59 44 66 36 U = 1,491; p = 0.019 70 41 69 26 U = 1,881; p = 0.019














































duration of symptoms was 5.7 years. Self-rated severity of
motor symptoms was moderately severe to very severe in 82%
of cases. A majority of patients reported confidence that the
diagnosis of a functional movement disorder was correct
(62%), but 54% felt the disorder was a mystery to them.
Patients reported poor quality of life (only 30% had good or
very good quality of life) and physical function impairment
(median 40 out of 100 [100 corresponding to unimpaired
functioning] and 26 out of 40 on the WSAS [40 corre-
sponding to poor functioning]).
Outcome
Main outcome
At 3 months, 44% (n = 31) of patients in the intervention
group reported improvement of their general health (“mini-
mally,” “much,” or “very much” improved), compared to 40%
(n = 26) of the controls on the CGI, which was not signifi-
cantly different. At 6 months, 42% (n = 35) of patients in the
intervention group reported to have improved, compared to
43% (n = 34) in the control group. Figure 2 shows the CGI
scale for both groups.
The sensitivity analysis with imputed data did not result in a
different main outcome.
To investigate potential harm, the number of patients with
worse general health on the CGI was compared between
groups. At 3 months, 20 (29%) patients in the intervention
group reported worse general health, compared to 18 controls
(28%) (U = 2,255, p = 0.910). At 6 months, 30 patients in the
intervention group (36%) had worse outcome, compared to
21 controls (27%) (U = 3,015, p = 0.210).
The per protocol analysis (where patients who never logged
on to the website were excluded from the intervention
group) did not show a significant difference between groups
(table 3).
A post hoc comparison showed that patients with paresis as
the main motor symptom might have benefitted less from
the intervention than patients with other motor symptoms.
Numbers were too small to perform statistical tests, but at 6
months, 45% of patients with paresis improved in the in-
tervention group, vs 41% with other motor symptoms, while
in the control group, this was 69% vs 38%, respectively
(figure 3).
Secondary outcomes
There were no differences between groups on any of the
outcome measures at 3 and 6 months follow-up, using a cutoff
for statistical significance of p < 0.01.
Symptom severity of all functional motor symptoms im-
proved in less than half of the patients (between 40% and
44%) at 3 and 6 months in both groups compared to baseline.
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group than in the control group at baseline, while at 3 and 6
months this equalized. Anxiety and health anxiety remained
stable over time in both groups, as well as pain, fatigue,
physical functioning, quality of life, and work and social
adjustment.
There were no significant differences between groups on the
illness perception questions. Agreement with the statement “I
am confident that the diagnosis of a functional disorder is
correct” was higher in the intervention group (62%) than in
the control group (47%) at 3 months, but this did not reach
significance (p = 0.014). Fewer than half of the patients (36%
of controls vs 41% of patients in the intervention group at 3
months, and 26% vs 41% at 6 months) believed physiotherapy
would improve their symptoms, and an even smaller number
believed psychotherapy would improve their symptoms (20%
of controls, 27% of patients in the intervention group at 3
months, 19% vs 20% at 6 months); neither changed signifi-
cantly over time. Overall satisfaction with their clinical care
(i.e., care other than the website) increased slightly over time
in both groups.
There were no statistically different outcomes from the per
protocol analysis (table 3).
Figure 2 Flow diagram (adapted from CONSORT [Consolidated Standards of Reporting Trials])
*Data missing at 3 months, but present at 6
months (and therefore these participants were
not lost to follow-up).
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Other websites and other treatments
During the study, 4 patients in the intervention group and 3
patients in the control group reported to have read in-
formation on the English website neurosymptoms.org.
Twelve percent of patients in the intervention group and 20%
in the control group (χ2 2.5, p = 0.111) visited one or more
other related websites.
In the first 3 months, 69% of the patients in the intervention
group received physiotherapy and 68% in the control group.
Respectively 33% and 37% received some form of psycho-
therapy. A total of 19% of the intervention group and 15% of
controls reported to have received no therapy at all. Between
3 and 6 months, 49% of the intervention group and 50% of
controls received physiotherapy, 23% and 26% respectively
received psychotherapy, and 17% and 18% respectively
reported to have received no therapy.
Hospital admissions
Twelve patients in the intervention group (14%) were ad-
mitted to the hospital during the 6 months follow-up period;
this was related to motor FND in 6 cases, unrelated in 4, and
there was missing information in 2 cases. Twelve controls
(15%) were admitted to the hospital during the 6 months
follow-up period: related to motor FND (n = 7), unrelated (n
= 4), or missing information (n = 1).
Post hoc correlations
Correlation between baseline variables and outcome
Duration of symptoms of more than 6 months at baseline
(mean duration at baseline was 5.7 years) was associated
with poor general health outcome at 6 months in a uni-
variable logistic regression model (odds ratio [OR] 2.80
[1.45–5.42], p = 0.002). Fifty-nine percent of patients with
short duration improved, compared to 37% with long (>6
months) duration of symptoms. This relationship was
stronger in the intervention group (interaction group ×
duration of symptoms, OR 1.84 [1.05–3.20], p = 0.033),
although not significantly. Outcome was worse in men (28%
of patients were men) (OR 2.94 [1.58–5.48], p = 0.001),
which was not significantly different between groups. A
number of variables were not significantly associated with
outcome in the entire cohort or in the groups separately: the
referring center (55% of patients were referred from an ac-
ademic center) (OR 1.49 [0.86–2.60], p = 0.158), older age
at onset (OR 1.02 [1.00–1.04], p = 0.026), “I am confident
that the diagnosis functional disorder is correct” (62%
agreed) (OR 1.14 [0.84–1.55], p = 0.405), “My disorder is a
mystery to me” (52% agreed) (OR 1.07 [0.86–1.33], p =
0.533), and “What I do determines the outcome of my dis-
order” (58% agreed) (OR 0.98 [0.77–1.24], p = 0.877).
Correlation between change in illness perceptions and outcome
The effect of change in understanding the diagnosis (mea-
sured on a change on 3 illness perception questions) on the
main outcome at 6 months (general health on the CGI) was
investigated by univariable ordinal regression. An increase in
agreement from baseline to 6 months with “I am confident
that the diagnosis functional disorder is correct” provided an
OR of 1.43 (1.12–1.83; p = 0.004) with good general health
(CGI) at 6 months in the entire cohort. When the random-
ization group was added as an interaction term, the OR was
1.42 (1.01–2.00; p = 0.044), indicating there was a trend
towards a bigger effect in the intervention group. A decrease
in agreement with “My disorder is a mystery to me” (OR 1.30
[1.02–1.63], p = 0.033), and an increase in agreement with
“What I do determines the outcome of my disorder” (OR 1.13
[0.93–1.36], p = 0.234), were not significantly associated with
outcome.
Evaluation of the education and self-help
website
Sixty-three patients in the intervention group (74% of the 85
who viewed the website at least once) filled out the evaluation.
Eighty-six percent of patients reported they would recom-
mend the website to other patients, 68% of patients found the
Figure 3 Main outcome: change in self-rated general health at 3 and 6 months compared to baseline in both groups
Neurology.org/N Neurology | Volume 95, Number 13 | September 29, 2020 e1893
Copyright © 2020 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
website very useful, and 67% performed the exercises pro-
vided on the website at some point during the 6 months
follow-up.
A smaller number of patients answered more detailed ques-
tions evaluating the website (n = 55). Seventy-eight percent
agreed with the explanation of their symptoms that was
provided on the website, 89% found the information on the
website was easy to understand, 22% perceived difficulty in
taking in the information, 49% agreed the information on the
website matched the explanation given by the neurologist
they had seen for their symptoms, and 75% reported they
would want to keep on using the website in the future. Of
them, 9% reported they felt angry or misunderstood (for di-
vergent and sometimes multiple) reasons: the website was
patronizing (n = 2), too negative (n = 1), a specific symptom
the patient had was not mentioned (n = 1), the website cre-
ated a stronger focus on the symptoms, which was unhelpful
(n = 1), physical exercises made the symptoms worse (n = 1),
and there was a discrepancy between the opinion of health
care providers in reality and the information on the website
(n = 1).
In additional comments, patients mentioned they experienced
health care providers seemed to lack knowledge on FND
(n = 10), which either impeded treatment generally or made
the website less helpful because of the lack of connection with
their experience of health care (some felt this was highly
frustrating). Others remarked the website was helpful to ed-
ucate their health care providers or explain the disorder to
relatives and friends. Several patients (n = 10)mentioned they
felt heard after reading the website and felt it validated their
experiences, or they were relieved to see other patients had
similar symptoms and impairments. Three patients asked for
an overview of health care providers with experience in this
field or a patient forum.
Discussion
In this RCT, there was no difference in self-rated general
health on the CGI scale at 3 or 6 months between motor
patients with FND who were directed towards an education
and self-help website in addition to usual care and patients
who received only usual care. Nor were there significant dif-
ferences on the secondary outcomes (severity of motor
symptoms, other physical and psychiatric symptoms, physical
functioning, quality of life, work and social adjustment, or
illness beliefs [including beliefs of the effect of physiotherapy/
psychotherapy and satisfaction with care]). Patient satisfac-
tion with the website was high. The per protocol analysis
results were similar to the primary intention-to-treat analysis.
We also showed that the intervention did no harm. Poor
outcomes and hospitalizations were similar in both arms.
Our results suggest nonguided online self-help is not effective
as a sole addition to usual care for motor FND. There are no
studies of unguided self-help and education for motor FND
to compare our data with. A meta-analysis of self-help in the
broader group of functional syndromes (chronic pain,
chronic fatigue, and irritable bowel syndrome) showed im-
provement of quality of life or symptom reduction of both
guided and unguided self-help, although outcome measures
were heterogeneous and there were only 5 unguided stud-
ies.11 A recent meta-analysis of treatment modalities in de-
pression also showed unguided self-help therapy was not
more effective than care as usual, while guided self-help
was.17 Our findings support patient group concerns, for
example expressed by individual patients and patient orga-
nizations that an unguided self-help website should not be
regarded as all that is needed to manage motor FND. Motor
symptoms improved in roughly 2 out of 5 patients sponta-
neously. This suggests that neurologists should follow pa-
tients with FND after diagnosis to monitor early
improvement and to direct the remaining 3 out of 5 patients
to further treatment, and not rely on the provision of in-
formation alone as treatment.
Providing patients with reliable and accessible information
does not need to resolve or even improve symptoms in
order to be justifiable. Explanation and education remain, in
our view, an essential element of stepped care for motor
FND. Improved confidence that the diagnosis was correct
correlated with improvement in health across the whole
cohort, and to a greater extent in the intervention group,
although the latter did not reach the predetermined
threshold (p < 0.01) for significance. Nonetheless this
suggests the right direction of travel in terms of improving
understanding. Treatment studies of motor FND using a
comparable educational model, either as a guided self-help
intervention6 or combined with physical and cognitive be-
havioral interventions in inpatient18–20 or outpatient21,22
settings, have shown favorable outcomes. In practice, pa-
tients often experience lack of availability of expert knowl-
edge, as reflected in patients’ written comments and the
finding that only half the patients (49%) agreed that the
information from the website matched the explanation of
the neurologist. This is a problem recognized by physicians
in the field2 and emphasizes the need for consistency be-
tween health professionals caring for the same patient.
The type and content of an optimal educational intervention
for motor FND, in which much remains unknown about
pathophysiology and treatment, can be debated. We chose a
conceptual model, based on our clinical experience and our
interpretation of contemporary scientific findings, that we
think is the best fit between accurate mechanistic descriptions
and patient acceptability. However, there are many unknowns
in this condition and this is an inherent problem with any
model. We described FND as a problem in nervous system
functioning but also did not ignore the importance of psy-
chological factors. The model aimed to promote self-efficacy
and to help patients see how they could take part in their own
rehabilitation. There was less emphasis on potential etiologic
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factors, partly as these vary between individuals and are dif-
ficult to address via self-help. This model has been criticized as
“depsychologizing” the condition and potentially causing
iatrogenic harm by suggesting that it is all a “brain” condition
and nothing therefore directing the patient away from tackling
psychological problems in their lives. Whereas we reject this
notion as dualistic and misunderstanding of our model, we
nonetheless accept that it is a valid criticism and a more ex-
plicitly psychological model may have led to improved out-
comes. In this regard, we note that there have been a number
of trials of the reattribution model, which is more explicitly
psychological, in so-called medically unexplained symptoms
that paradoxically showed poorer patient outcomes.23 There
is a separate theoretical concern that any form of education
may ask patients to spend too long reading or thinking about
their disorder and could have an amplifying effect on
symptomatology.
The study had several additional possible limitations. Patients
in our study had a long duration of symptoms (mean of 5.6
years), which may have negatively influenced outcomes, as we
found that symptom duration correlated to worse outcome.
Prognostic studies3 in general have found that a longer du-
ration of symptoms correlates with poorer prognosis. Early
educational intervention seems beneficial in some conditions
commonly comorbid with motor FND.24,25
The fact that we employed liberal inclusion criteria and ad-
vertised the study broadly (with good result: 31 centers, both
academic and nonspecialized, referred patients) improved
generalizability. This is to date the largest RCT in any FND.
The overall improvement of motor symptoms in 40%–44% of
patients is comparable to other cohorts.26,27 However, selec-
tion bias most likely occurred at patient level (patients who
did not believe the diagnosis were less likely to enroll) and
physician level (neurologists with an interest in FND would
be more likely to refer into the study). A large number of
patients (n = 128) refused to take part. In addition, 17 patients
never completed the baseline questionnaires and many pa-
tients only viewed the website a few times. There may have
been issues with accessibility and readability although we did
not receive negative feedback regarding these from patient
evaluation.
Outcomes might also have been influenced because the study
was not blinded and a nocebo effect in the control group
could have occurred. However, this effect is likely to be small
in this low-intensity study. Use of alternative websites like
neurosymptoms.org was low and equal between groups.
Furthermore, the study website was different from neuro-
symptoms.org, in that it provided a program of information to
work through, and numerous videos and examples not avail-
able elsewhere. Our patient cohort might have been too small
to capture subtle differences in secondary outcomes. The
follow-up period was relatively short and therefore long-term
effects, for example on compliance with or effect of further
treatments, might have been missed. The fact that the study
was Internet-based, compared to on paper, did not appear to
cause problems in inclusion or follow-up in the large majority
of patients.
Measuring outcome in (motor) FND is complicated by the
heterogeneity of the population and the symptoms them-
selves. We chose a self-rated general health scale (CGI) as the
main outcome because this is the most clinically relevant for a
complex heterogeneous and variable disorder and is less
susceptible to floor and ceiling effects than other scales. Self-
rated measures are ultimately subjective, although a recent
international collaboration concluded that this was preferable
to objective measures for this particular disorder.28 Physician-
rated and objective measures would have provided a com-
plementary and useful perspective but can be problematic in a
variable fluctuating disorder.
In this first randomized controlled trial of an online education
and self-help program for motor FND, we found it was well
received but it did not lead to improvements in self-rated
general health on the CGI scale at 3 or 6 months, nor did it
lead to any harmful effects.
Nonetheless, provision of information is a core part of
clinician–patient interaction, and this trial shows it can be
done safely in FND. Patients with FND have the same rights
as other patients to be informed of the nature of their con-
dition, but the provision of such information is insufficient on
its own to alter clinically relevant outcomes in motor FND
compared to usual care.
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